Supplement
Reishi is a mushroom used in traditional Asian medicine, rich in beta-glucans, compounds that interact with immune cells in the body. People mostly look at it for support during cancer care, and small trials found immune measures improved in patients, though the evidence is limited. Those studies were small, with only a few dozen participants in total, and trials on prostate symptoms and blood flow found no clear difference, so the picture is still early.
Sources: PMID 16428086; PMID 17597499
- Updated
- How we grade
- 13 studies cited
- Best evidence
- Grade C
- Conditions studied
- 11
- Outcomes
- 53
- Graded outcomes
- 0055
Evidence by condition
- Strong
- Moderate
- Limited
- Very limited
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Immunity Small Improvement | Improves (the measure goes up) | Small effect | 3 studies | 34 people | ||
Studies that measured immunity
| ||||||
| Natural Killer Cell Activity | Improves (the measure goes up) | 34 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 34 people | ||||
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| CD3 Lymphocytes Small Increase | Improves (the measure goes up) | Small effect | 1 study | 40 people | ||
Studies that measured cd3 lymphocytes | ||||||
| CD4 Lymphocytes Small Increase | Improves (the measure goes up) | Small effect | 40 people | |||
| Immunity | Improves (the measure goes up) | 3 studies | 97 people | |||
Studies that measured immunity
| ||||||
| Proteinuria | Improves (the measure goes up) | 1 study | 14 people | |||
| Natural Killer Cell Activity | Improves (the measure goes up) | 34 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 34 people | ||||
Breast Cancer
- Anxiety Symptoms: improves
- Depression Symptoms: improves
- Fatigue Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anxiety Symptoms Small Improvement | Improves (the measure goes down) | Small effect | 1 study | 48 people | ||
Studies that measured anxiety symptoms | ||||||
| Depression Symptoms | Improves (the measure goes down) | 48 people | ||||
| Fatigue Symptoms | Improves (the measure goes down) | 48 people | ||||
| Subjective Well-Being | Improves (the measure goes up) | 48 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 48 people | ||||
Neurasthenia
- Fatigue Symptoms: improves
- Neurasthenia Symptoms: improves
- Subjective Well-Being: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Fatigue Symptoms Small Improvement | Improves (the measure goes down) | Small effect | 132 people | |||
| Neurasthenia Symptoms | Improves (the measure goes down) | 1 study | 132 people | |||
Studies that measured neurasthenia symptoms | ||||||
| Subjective Well-Being | Improves (the measure goes up) | 132 people | ||||
Lower Urinary Tract Symptoms
- Benign Prostatic Hyperplasia Symptoms
- Lower Urinary Tract Symptoms: improves
- Prostate-Specific Antigen: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Benign Prostatic Hyperplasia Symptoms No effect | NoneNo effect | 2 studies | 138 people | |||
Studies that measured benign prostatic hyperplasia symptoms | ||||||
| Lower Urinary Tract Symptoms | Improves (the measure goes down) | 138 people | ||||
| Prostate-Specific Antigen | Improves (the measure goes up) | 138 people | ||||
| Subjective Well-Being | Improves (the measure goes up) | 50 people | ||||
| Testosterone | Improves (the measure goes up) | 88 people | ||||
General Cardiovascular Health
- Blood Flow
- Proteinuria: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Flow No effect | NoneNo effect | 1 study | 40 people | |||
| Proteinuria | Improves (the measure goes up) | 1 study | 14 people | |||
High Blood Pressure
- Adrenaline
- Anti-Oxidant Enzyme Profile: improves
- Blood Pressure: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adrenaline No effect | NoneNo effect | 1 study | 23 people | |||
Studies that measured adrenaline | ||||||
| Anti-Oxidant Enzyme Profile | Improves (the measure goes up) | 23 people | ||||
| Blood Pressure | Improves (the measure goes down) | 23 people | ||||
| Dopamine | Improves (the measure goes up) | 23 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 23 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 23 people | ||||
| Triglycerides | Improves (the measure goes down) | 23 people | ||||
| Weight | Improves (the measure goes down) | 23 people | ||||
High Cholesterol
- Adrenaline
- Anti-Oxidant Enzyme Profile: improves
- Blood Pressure: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adrenaline No effect | NoneNo effect | 1 study | 23 people | |||
Studies that measured adrenaline | ||||||
| Anti-Oxidant Enzyme Profile | Improves (the measure goes up) | 23 people | ||||
| Blood Pressure | Improves (the measure goes down) | 23 people | ||||
| Dopamine | Improves (the measure goes up) | 23 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 23 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 23 people | ||||
| Triglycerides | Improves (the measure goes down) | 23 people | ||||
| Weight | Improves (the measure goes down) | 23 people | ||||
Metabolic Health
- Anti-Oxidant Enzyme Profile
- Immunity: improves
- Total cholesterol: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anti-Oxidant Enzyme Profile No effect | NoneNo effect | 18 people | ||||
| Immunity | Improves (the measure goes up) | 3 studies | 18 people | |||
Studies that measured immunity
| ||||||
| Total cholesterol | Improves (the measure goes down) | 1 study | 18 people | |||
Studies that measured total cholesterol | ||||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 18 people | ||||
| DNA Damage | Changes; see studies | 18 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 18 people | ||||
| Liver Enzymes | Changes; see studies | 18 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 18 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 18 people | ||||
| Triglycerides | Improves (the measure goes down) | 18 people | ||||
| Uric Acid | Improves (the measure goes down) | 18 people | ||||
Colorectal Cancer
- Colorectal Cancer Risk: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Colorectal Cancer Risk | Improves (the measure goes down) | 1 study | 198 people | |||
Studies that measured colorectal cancer risk | ||||||
Kidney Health
- Proteinuria: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Proteinuria | Improves (the measure goes up) | 1 study | 14 people | |||
Key findings
- ImmunityImproves (the measure goes up)
- CD3 LymphocytesImproves (the measure goes up)
- Anxiety SymptomsImproves (the measure goes down)
Shop Reishi
Third-party tested Reishi products. The evidence above is limited, so read it before you buy.
- Grade C
Links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Fullscript asks for a free account before it shows its catalog and prices. Full disclosure
Studies cited
13 studies from PubMed
- Randomized clinical trial of an ethanol extract of Ganoderma lucidum in men with lower urinary tract symptoms
- Effect of an extract of Ganoderma lucidum in men with lower urinary tract symptoms: a double-blind, placebo-controlled randomized and dose-ranging study
- A randomized, double-blind and placebo-controlled study of a Ganoderma lucidum polysaccharide extract in neurasthenia
- Study of potential cardioprotective effects of Ganoderma lucidum (Lingzhi): results of a controlled human intervention trial
- Ganoderma lucidum ("Lingzhi"), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation study
- Monitoring of immune responses to a herbal immuno-modulator in patients with advanced colorectal cancer
- Safety and tolerability of Ganoderma lucidum in healthy subjects: a double-blind randomized placebo-controlled trial
- Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients
- Ganoderma lucidum suppresses endothelial cell cytotoxicity and proteinuria in persistent proteinuric focal segmental glomerulosclerosis (FSGS) nephrosis
- Effect of Ganoderma lucidum capsules on T lymphocyte subsets in football players on "living high-training low"
- A water-soluble extract from culture medium of Ganoderma lucidum mycelia suppresses the development of colorectal adenomas
- Spore Powder of Ganoderma lucidum Improves Cancer-Related Fatigue in Breast Cancer Patients Undergoing Endocrine Therapy: A Pilot Clinical Trial
- A prospective, randomized, double-blind, placebo-controlled study of the platelet and global hemostatic effects of Ganoderma lucidum (Ling-Zhi) in healthy volunteers